Tumor-selective combination therapy

Paul J Hergenrother (Inventor), David A Boothman (Inventor), Joseph S Bair (Inventor), Lifen Cao (Inventor), Jinming Gao (Inventor), Xiumei Huang (Inventor), Xiuquan Luo (Inventor), Xinpeng Ma (Inventor), Zachary Moore (Inventor), Elizabeth I Parkinson (Inventor)

Research output: Patent


The therapies described herein can be selectively lethal toward a variety of different cancer cell types and cancer conditions in a subject. The combination therapies described herein can be useful for the management, treatment, control, or adjunct treatment of diseases, where the selective lethality is beneficial in chemotherapeutic therapy, particularly where the disease is accompanied by elevated levels of NQO1.
Original languageEnglish (US)
U.S. patent number10272099
StatePublished - Apr 30 2019


Dive into the research topics of 'Tumor-selective combination therapy'. Together they form a unique fingerprint.

Cite this